» Articles » PMID: 20175530

Intramolecular Hydrogen Bonding in Medicinal Chemistry

Overview
Journal J Med Chem
Specialty Chemistry
Date 2010 Feb 24
PMID 20175530
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

The formation of intramolecular hydrogen bonds has a very pronounced effect on molecular structure and properties. We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chemistry. On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramolecular hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery. A number of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small molecule and protein-ligand X-ray structures. To investigate effects on physicochemical properties, sets of closely related structures with and without the ability to form intramolecular hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water solubility, and lipophilicity. We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments. A number of general guidelines for medicinal chemists emerge from this study.

Citing Articles

Structural Basis for the Improved RNA Clamping of Amidino-Rocaglates to eIF4A1.

Conley J, Brown L, McNeely J, Pelletier J, Porco Jr J, Allen K ACS Omega. 2025; 10(6):5795-5808.

PMID: 39989799 PMC: 11840593. DOI: 10.1021/acsomega.4c09421.


Impact of Linker Composition on VHL PROTAC Cell Permeability.

Abeje Y, Wieske L, Poongavanam V, Maassen S, Atilaw Y, Cromm P J Med Chem. 2024; 68(1):638-657.

PMID: 39693386 PMC: 11726670. DOI: 10.1021/acs.jmedchem.4c02492.


Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors.

Zheng J, Zhang W, Ni D, Zhao S, He Y, Hu J ACS Med Chem Lett. 2024; 15(11):2019-2031.

PMID: 39563808 PMC: 11571013. DOI: 10.1021/acsmedchemlett.4c00431.


Repurposed pharmacotherapy: targeting cathepsin L with repurposed drugs in virtual screening.

Khalid M, Alqarni M, Foudah A Mol Divers. 2024; .

PMID: 39470912 DOI: 10.1007/s11030-024-11022-4.


MetaCGRP is a high-precision meta-model for large-scale identification of CGRP inhibitors using multi-view information.

Schaduangrat N, Khemawoot P, Jiso A, Charoenkwan P, Shoombuatong W Sci Rep. 2024; 14(1):24764.

PMID: 39433940 PMC: 11494111. DOI: 10.1038/s41598-024-75487-x.